PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsCIRM gives $243m more funding to stem cell research

BioNews

CIRM gives $243m more funding to stem cell research

Published 27 August 2010 posted in News and appears in BioNews 573

Author

Nishat Hyder

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).

The California Institute for Regenerative Medicine (CIRM) in San Francisco has approved a further $243 million to encourage researchers working on stem cell therapies to push forward into the clinical trial phase...

The California Institute for Regenerative Medicine (CIRM) in San Francisco has approved a further $243 million to encourage researchers working on stem cell therapies to push forward into the clinical trial phase. Experts believe this funding could prove critical in developing viable treatments for conditions such as Alzheimer's disease, diabetes and spinal cord injuries.

This is the second round of funding that the CIRM has approved for stem cell research, and is aimed at multidisciplinary research teams. The application process involves two stages. Initially, 35 Planning Awards of up to $110,000 will be given to lead investigators, enabling them to put together scientific teams, and to plan and prepare for the Disease Team Award application.

Following this, the 35 applications will be assessed, with up to 12 teams being given a Disease Team Award, worth up to $20 million. Only recipients of the initial planning grant are able to apply for a Disease Team Award. Successful teams are expected to file a request to proceed with clinical trials, or complete Phase I or Phase II trials within four years.

In the first round of CIRM funding, $250 million was awarded to 14 disease teams. These included joint teams from the University of California in San Francisco (UCSF) with Novocell Incorporated, and UCSF's Ludwig Institute for Cancer Research with Burnham Institute for Medical Research, who are researching diabetes and brain tumours, respectively.

The application process will open in November this year, and full awards are expected to be approved in 2012.

Related Articles

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
25 March 2013 • 2 minutes read

Multimillion-dollar grants for stem cell biobank

by Dr Shanya Sivakumaran

The California Institute for Regenerative Medicine in San Francisco, USA, has awarded two multimillion-dollar grants to Cellular Dynamics International in Wisconsin and Coriell Institute for Medical Research in New Jersey to generate and bank iPS cell lines....

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
7 December 2012 • 1 minute read

$3 billion California stem cell agency 'make proposals to themselves regarding what should be funded'

by Dr Anna Cauldwell

A report has drawn attention to the potential for conflict of interest at the agency that allocates state funds to stem cell research in California, USA...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
29 November 2012 • 1 minute read

Scottish stem cell research given a boost

by Dr Antony Starza-Allen

A new fund to help pay for stem cell research in Scotland has been launched. The UK Stem Cell Foundation (UKSF) will aim to raise £5 million over three years to support the work of researchers and clinicians in Scotland into treatments and cures for illnesses including diabetes, strokes, multiple sclerosis, blindness and Alzheimer's disease...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
17 October 2012 • 1 minute read

Cells grown in lab could help research into Alzheimer's disease

by Alison Cranage

Scientists at Northwestern University, Chicago have transformed stem cells into a key type of brain cell that dies early in Alzheimer's disease. Their findings will allow scientists to study what causes the cells to die in Alzheimer's, potentially paving the way for new treatments....

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
6 November 2009 • 2 minutes read

$230 million cash boost aimed at driving stem cell therapies into the clinic

by Nisha Satkunarajah

The California Institute for Regenerative Medicine (CIRM) has awarded fourteen teams a total of $230 million for the advancement of stem cell therapy. The CIRM was created as a measure by the Californian State to fund work on human embryonic stem (ES) cells.Californian voters approved the 10-year, $3 billion effort in 2004 largely to get around restrictions on ES cell research imposed by the administration of President George W Bush. This year, President Obama's administration relaxed thes...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 June 2009 • 1 minute read

California awards $59 million in support of stem cell research

by MacKenna Roberts

The governing board of California's stem cell agency awarded $59 million in research grants for the second cycle of an ongoing funding initiative, referred to as 'New Faculty Grants', targeting promising researchers and physicians early in their career entering the stem cell sciences. Twenty-three applicants from among...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 June 2009 • 2 minutes read

Alan Trounson to head California stem cell institute

by Dr Kirsty Horsey

The California Institute of Regenerative Medicine (CIRM) has appointed Professor Alan Trounson as its new president, following a committee vote on Friday last week. Professor Trounson is a renowned Australian scientist and currently the director of Monash University's stem cell program in Melbourne. The CIRM is...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
9 June 2009 • 2 minutes read

Californian court backs state stem cell research initiative

by MacKenna Roberts

The California First District Court of Appeal in San Francisco unanimously ruled on 26 February that 'Proposition 71' is constitutional, strongly affirming that it 'suffers from no constitutional or other legal infirmity'. Proposition 71 called for the creation of the California Institute for Regenerative Medicine (CIRM), its...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« British DNA scientist was suspected of spying for Russia

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856